Annual report

Period2021-04-01 → 2022-03-31
Filed2022-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 149
MetricValuePeriodScopeSource row
Revenue¥12.6bn2021-04-01 → 2022-03-31Cons.Net sales
Revenue¥11.0bn2020-04-01 → 2021-03-31Cons.Net sales
Revenue¥11.0bn2019-04-01 → 2020-03-31dCons.Net sales (5-year summary)
Revenue¥8.7bn2018-04-01 → 2019-03-31dCons.Net sales (5-year summary)
Revenue¥3.6bn2017-04-01 → 2018-03-31dCons.Net sales (5-year summary)
Operating income¥1.8bn2021-04-01 → 2022-03-31Cons.Operating income
Operating income¥893m2020-04-01 → 2021-03-31Cons.Operating income
Ordinary income¥1.8bn2021-04-01 → 2022-03-31Cons.Ordinary income
Ordinary income¥892m2020-04-01 → 2021-03-31Cons.Ordinary income
Ordinary income¥95m2019-04-01 → 2020-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥256m2018-04-01 → 2019-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥14m2017-04-01 → 2018-03-31dCons.Ordinary income loss (5-year summary)
Profit before tax¥2.8bn2021-04-01 → 2022-03-31Cons.Income before income taxes
Profit before tax¥695m2020-04-01 → 2021-03-31Cons.Income before income taxes
Net income (owners)¥1.9bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥546m2020-04-01 → 2021-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥441m2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥202m2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥21m2017-04-01 → 2018-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥1.9bn2021-04-01 → 2022-03-31Cons.Profit loss
Net income¥542m2020-04-01 → 2021-03-31Cons.Profit loss
Total assets¥10.4bnat 2022-03-31Cons.Assets
Total assets¥8.9bnat 2021-03-31Cons.Assets
Total assets¥7.6bnat 2020-03-31dCons.Total assets (5-year summary)
Total assets¥6.5bnat 2019-03-31dCons.Total assets (5-year summary)
Total assets¥5.9bnat 2018-03-31dCons.Total assets (5-year summary)
Total liabilities¥3.8bnat 2022-03-31Cons.Liabilities
Total liabilities¥3.9bnat 2021-03-31Cons.Liabilities
Net assets / equity¥6.6bnat 2022-03-31Cons.Net assets
Net assets / equity¥5.0bnat 2021-03-31Cons.Net assets
Net assets / equity¥4.4bnat 2020-03-31dCons.Net assets
Net assets / equity¥4.9bnat 2019-03-31dCons.Net assets (5-year summary)
Net assets / equity¥4.3bnat 2018-03-31dCons.Net assets (5-year summary)
Cash and deposits¥4.6bnat 2022-03-31Cons.Cash and deposits
Cash and deposits¥3.0bnat 2021-03-31Cons.Cash and deposits
Cash & equivalents¥4.6bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥3.0bnat 2021-03-31Cons.Cash and cash equivalents
Cash & equivalents¥1.6bnat 2020-03-31dCons.Cash and cash equivalents
Cash & equivalents¥1.3bnat 2019-03-31dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥1.8bnat 2018-03-31dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥1.8bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.2bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥21m2019-04-01 → 2020-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥148m2018-04-01 → 2019-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥219m2017-04-01 → 2018-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow¥982m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investment activities
Investing cash flow¥48m2020-04-01 → 2021-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥319m2019-04-01 → 2020-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥835m2018-04-01 → 2019-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥552m2017-04-01 → 2018-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥1.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities
Financing cash flow¥10m2020-04-01 → 2021-03-31Cons.Net cash provided by used in financing activities
Financing cash flow¥667m2019-04-01 → 2020-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥194m2018-04-01 → 2019-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.0bn2017-04-01 → 2018-03-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥109.522021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥31.452020-04-01 → 2021-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-25.382019-04-01 → 2020-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥11.952018-04-01 → 2019-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥1.412017-04-01 → 2018-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥109.312021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥31.452020-04-01 → 2021-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥11.912018-04-01 → 2019-03-31dCons.Diluted earnings per share (5-year summary)
EPS (diluted)¥1.392017-04-01 → 2018-03-31dCons.Diluted earnings per share (5-year summary)
Net assets per share¥388.43at 2022-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥283.07at 2021-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥254.29at 2020-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥281.32at 2019-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥265.64at 2018-03-31dCons.Net assets per share (5-year summary)
Equity ratio62.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio55.1%at 2021-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio58.3%at 2020-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio75.4%at 2019-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio73.0%at 2018-03-31dCons.Equity to asset ratio (5-year summary)
ROE32.8%2021-04-01 → 2022-03-31Cons.Rate of return on equity (5-year summary)
ROE11.7%2020-04-01 → 2021-03-31Cons.Rate of return on equity (5-year summary)
ROE4.4%2018-04-01 → 2019-03-31dCons.Rate of return on equity (5-year summary)
ROE0.6%2017-04-01 → 2018-03-31dCons.Rate of return on equity (5-year summary)
Employees213at 2022-03-31Cons.Number of employees
Employees248at 2021-03-31Cons.Number of employees
Employees250at 2020-03-31dCons.Number of employees
Employees223at 2019-03-31dCons.Number of employees
Employees162at 2018-03-31dCons.Number of employees
Revenue¥365m2021-04-01 → 2022-03-31StandaloneOperating revenue1
Revenue¥377m2020-04-01 → 2021-03-31StandaloneNet sales
Revenue¥437m2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥456m2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Revenue¥417m2017-04-01 → 2018-03-31dStandaloneNet sales (5-year summary)
Operating income¥78m2021-04-01 → 2022-03-31StandaloneOperating income
Operating income−¥69m2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income¥76m2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥32m2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income−¥62m2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥32m2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥45m2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥3.0bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax¥35m2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income¥2.7bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥180m2020-04-01 → 2021-03-31StandaloneProfit loss
Net income−¥298m2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥38m2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income−¥8m2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥7.6bnat 2022-03-31StandaloneAssets
Total assets¥4.7bnat 2021-03-31StandaloneAssets
Total assets¥4.5bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥4.9bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥4.6bnat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥796mat 2022-03-31StandaloneLiabilities
Total liabilities¥338mat 2021-03-31StandaloneLiabilities
Net assets / equity¥6.8bnat 2022-03-31StandaloneNet assets
Net assets / equity¥4.4bnat 2021-03-31StandaloneNet assets
Net assets / equity¥4.2bnat 2020-03-31dStandaloneNet assets
Net assets / equity¥4.5bnat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥4.1bnat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥3.0bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥728mat 2021-03-31StandaloneCash and deposits
EPS (basic)¥158.32021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥10.362020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-17.142019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥2.272018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-0.572017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥1582021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥10.362020-04-01 → 2021-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥2.272018-04-01 → 2019-03-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥62021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥32020-04-01 → 2021-03-31StandaloneDividend paid per share (5-year summary)
Net assets per share¥406.51at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥252.79at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥242.23at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥261.36at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥253.86at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio89.6%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio92.8%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio93.4%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio93.5%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio89.1%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE48.3%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE4.2%2020-04-01 → 2021-03-31StandaloneRate of return on equity (5-year summary)
ROE0.9%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued17,369,141at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued17,369,141at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued17,369,141at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued17,358,141at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued16,303,941at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees7at 2022-03-31StandaloneNumber of employees
Employees25at 2021-03-31StandaloneNumber of employees
Employees26at 2020-03-31dStandaloneNumber of employees
Employees27at 2019-03-31dStandaloneNumber of employees
Employees27at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 86
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2021-04-01 → 2022-03-31¥394,000
Reconciling Itemsreconcilingdepreciation2021-04-01 → 2022-03-31¥447,000
Reconciling Itemsreconcilingrevenue2021-04-01 → 2022-03-31−¥13m
Reconciling Itemsreconcilingrevenue external2021-04-01 → 2022-03-31¥600,000
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2022-03-31−¥14m
Reconciling Itemsreconcilingsegment assetsat 2022-03-31¥5.0bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2022-03-31−¥210m
Drug Discovery Support Businessreportable segmentcapex2021-04-01 → 2022-03-31¥620m
Drug Discovery Support Businessreportable segmentdepreciation2021-04-01 → 2022-03-31¥139m
Drug Discovery Support Businessreportable segmentemployeesat 2022-03-31147 pure
Drug Discovery Support Businessreportable segmentrevenue2021-04-01 → 2022-03-31¥4.8bn
Drug Discovery Support Businessreportable segmentrevenue external2021-04-01 → 2022-03-31¥4.8bn
Drug Discovery Support Businessreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥11m
Drug Discovery Support Businessreportable segmentsegment assetsat 2022-03-31¥3.0bn
Drug Discovery Support Businessreportable segmentsegment profit2021-04-01 → 2022-03-31¥1.8bn
E Commerce Businessreportable segmentcapex2021-04-01 → 2022-03-31¥5m
E Commerce Businessreportable segmentdepreciation2021-04-01 → 2022-03-31¥3m
E Commerce Businessreportable segmentrevenue2021-04-01 → 2022-03-31¥4.7bn
E Commerce Businessreportable segmentrevenue external2021-04-01 → 2022-03-31¥4.7bn
E Commerce Businessreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥601,000
E Commerce Businessreportable segmentsegment assetsat 2022-03-31¥1.0bn
E Commerce Businessreportable segmentsegment profit2021-04-01 → 2022-03-31¥157m
Othersreportable segmentcapex2021-04-01 → 2022-03-31¥11m
Othersreportable segmentdepreciation2021-04-01 → 2022-03-31¥9m
Othersreportable segmentrevenue2021-04-01 → 2022-03-31¥3.1bn
Othersreportable segmentrevenue external2021-04-01 → 2022-03-31¥3.1bn
Othersreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥3m
Othersreportable segmentsegment assetsat 2022-03-31¥1.4bn
Othersreportable segmentsegment profit2021-04-01 → 2022-03-31¥115m
TGBS Businessreportable segmentcapex2021-04-01 → 2022-03-31¥16m
TGBS Businessreportable segmentdepreciation2021-04-01 → 2022-03-31¥12m
TGBS Businessreportable segmentemployeesat 2022-03-3159 pure
TGBS Businessreportable segmentrevenue2021-04-01 → 2022-03-31¥7.8bn
TGBS Businessreportable segmentrevenue external2021-04-01 → 2022-03-31¥7.8bn
TGBS Businessreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥3m
TGBS Businessreportable segmentsegment assetsat 2022-03-31¥2.4bn
TGBS Businessreportable segmentsegment profit2021-04-01 → 2022-03-31¥271m
—segment totalemployeesat 2022-03-31206 pure
Total Of Reportable Segments And Otherssegment totalcapex2021-04-01 → 2022-03-31¥636m
Total Of Reportable Segments And Otherssegment totaldepreciation2021-04-01 → 2022-03-31¥152m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2022-03-31¥12.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2022-03-31¥12.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2022-03-31¥14m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-03-31¥5.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2022-03-31¥2.0bn
Reconciling Itemsreconcilingcapex2020-04-01 → 2021-03-31¥889,000
Reconciling Itemsreconcilingdepreciation2020-04-01 → 2021-03-31¥382,000
Reconciling Itemsreconcilingrevenue2020-04-01 → 2021-03-31−¥24m
Reconciling Itemsreconcilingrevenue intersegment2020-04-01 → 2021-03-31−¥24m
Reconciling Itemsreconcilingsegment assetsat 2021-03-31¥3.5bn
Reconciling Itemsreconcilingsegment profit2020-04-01 → 2021-03-31−¥178m
Drug Discovery Support Businessreportable segmentcapex2020-04-01 → 2021-03-31¥321m
Drug Discovery Support Businessreportable segmentdepreciation2020-04-01 → 2021-03-31¥159m
Drug Discovery Support Businessreportable segmentrevenue2020-04-01 → 2021-03-31¥3.6bn
Drug Discovery Support Businessreportable segmentrevenue external2020-04-01 → 2021-03-31¥3.6bn
Drug Discovery Support Businessreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥21m
Drug Discovery Support Businessreportable segmentsegment assetsat 2021-03-31¥3.4bn
Drug Discovery Support Businessreportable segmentsegment profit2020-04-01 → 2021-03-31¥745m
E Commerce Businessreportable segmentcapex2020-04-01 → 2021-03-31¥5m
E Commerce Businessreportable segmentdepreciation2020-04-01 → 2021-03-31¥3m
E Commerce Businessreportable segmentrevenue2020-04-01 → 2021-03-31¥5.3bn
E Commerce Businessreportable segmentrevenue external2020-04-01 → 2021-03-31¥5.3bn
E Commerce Businessreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥444,000
E Commerce Businessreportable segmentsegment assetsat 2021-03-31¥1.0bn
E Commerce Businessreportable segmentsegment profit2020-04-01 → 2021-03-31¥234m
Othersreportable segmentcapex2020-04-01 → 2021-03-31¥12m
Othersreportable segmentdepreciation2020-04-01 → 2021-03-31¥8m
Othersreportable segmentrevenue2020-04-01 → 2021-03-31¥2.2bn
Othersreportable segmentrevenue external2020-04-01 → 2021-03-31¥2.2bn
Othersreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥3m
Othersreportable segmentsegment assetsat 2021-03-31¥996m
Othersreportable segmentsegment profit2020-04-01 → 2021-03-31¥91m
TGBS Businessreportable segmentcapex2020-04-01 → 2021-03-31¥18m
TGBS Businessreportable segmentdepreciation2020-04-01 → 2021-03-31¥11m
TGBS Businessreportable segmentrevenue2020-04-01 → 2021-03-31¥7.5bn
TGBS Businessreportable segmentrevenue external2020-04-01 → 2021-03-31¥7.5bn
TGBS Businessreportable segmentrevenue intersegment2020-04-01 → 2021-03-31¥3m
TGBS Businessreportable segmentsegment assetsat 2021-03-31¥2.0bn
TGBS Businessreportable segmentsegment profit2020-04-01 → 2021-03-31¥325m
Total Of Reportable Segments And Otherssegment totalcapex2020-04-01 → 2021-03-31¥339m
Total Of Reportable Segments And Otherssegment totaldepreciation2020-04-01 → 2021-03-31¥170m
Total Of Reportable Segments And Otherssegment totalrevenue2020-04-01 → 2021-03-31¥11.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2020-04-01 → 2021-03-31¥11.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2020-04-01 → 2021-03-31¥24m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2021-03-31¥5.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2020-04-01 → 2021-03-31¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,536
ItemContextValueUnit
Valuation difference on available for sale securitiesCurrentYearInstant1066000JPY
Foreign currency translation adjustmentPrior1YearInstant1748000JPY
Foreign currency translation adjustmentCurrentYearInstant14851000JPY
Valuation and translation adjustmentsPrior1YearInstant-84126000JPY
Valuation and translation adjustmentsCurrentYearInstant15918000JPY
Subscription rights to sharesPrior1YearInstant200000JPY
Subscription rights to sharesCurrentYearInstant200000JPY
Non controlling interestsPrior1YearInstant120444000JPY
Non controlling interestsCurrentYearInstant104007000JPY
Net assetsPrior1YearInstant5036903000JPY
Net assetsCurrentYearInstant6636782000JPY
Liabilities and net assetsPrior1YearInstant8918812000JPY
Liabilities and net assetsCurrentYearInstant10440710000JPY
Net salesPrior1YearDuration11046139000JPY
Net salesCurrentYearDuration12576568000JPY
Cost of salesPrior1YearDuration8269034000JPY
Cost of salesCurrentYearDuration8740599000JPY
Gross profitPrior1YearDuration2777105000JPY
Gross profitCurrentYearDuration3835968000JPY
Selling general and administrative expensesPrior1YearDuration1883909000JPY
Selling general and administrative expensesCurrentYearDuration1998667000JPY
Operating incomePrior1YearDuration893195000JPY
Operating incomeCurrentYearDuration1837301000JPY
Interest income noiPrior1YearDuration2252000JPY
Interest income noiCurrentYearDuration761000JPY
Dividends income noiPrior1YearDuration57000JPY
Dividends income noiCurrentYearDuration76000JPY
Foreign exchange gains noiPrior1YearDuration-JPY
Foreign exchange gains noiCurrentYearDuration20281000JPY
Compensation income noiPrior1YearDuration7656000JPY
Compensation income noiCurrentYearDuration-JPY
Insurance income noiPrior1YearDuration-JPY
Insurance income noiCurrentYearDuration8248000JPY
Insurance premiums refunded cancellation noiPrior1YearDuration24424000JPY
Insurance premiums refunded cancellation noiCurrentYearDuration31991000JPY
Reversal of allowance for doubtful accounts noiPrior1YearDuration2449000JPY
Reversal of allowance for doubtful accounts noiCurrentYearDuration-JPY
Other noiPrior1YearDuration36447000JPY
Other noiCurrentYearDuration9142000JPY
Non operating incomePrior1YearDuration73288000JPY
Non operating incomeCurrentYearDuration70503000JPY
Interest expenses noePrior1YearDuration27275000JPY
Interest expenses noeCurrentYearDuration22636000JPY
Bond issuance cost and other noePrior1YearDuration1109000JPY
Bond issuance cost and other noeCurrentYearDuration-JPY
Acquisition expenses noePrior1YearDuration23697000JPY
Acquisition expenses noeCurrentYearDuration38092000JPY
Other noePrior1YearDuration22529000JPY
Other noeCurrentYearDuration27642000JPY
Non operating expensesPrior1YearDuration74611000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2021-03-31pass
balance sheet identityconsolidated 2022-03-31pass
balance sheet identitynon_consolidated 2021-03-31pass rounding
balance sheet identitynon_consolidated 2022-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2020-03-31pass
statement vs summary · net assetsconsolidated 2021-03-31pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2020-04-01/2021-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2020-04-01/2021-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsconsolidated 2021-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass